, Tracking Stock Market Picks
Enter Symbol:
Horizon Pharma Inc (HZNP) [hlAlert]

up 267.30 %

Horizon Pharma Inc. (HZNP) rated Buy with price target $12 by Stifel Nicolaus

Posted on: Wednesday,  Sep 7, 2011  8:25 AM ET by Stifel Nicolaus

Stifel Nicolaus rated Buy Horizon Pharma Inc (NASDAQ: HZNP) on 09/07/2011, when the stock price was $8.35. Since
then, Horizon Pharma Inc has gained 267.31% as of 01/19/2016's recent price of $30.67.
If you would have followed this Stifel Nicolaus's recommendation on HZNP, you would have gained 267.3% of your investment in 1595 days.

Horizon Pharma, Inc. (Horizon) is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. On April 23, 2011, the United States Food and Drug Administration, approved DUEXIS (formerly HZT-501), a tablet formulation containing a fixed-dose combination of ibuprofen and famotidine in a single pill. The Company?s other product, LODOTRA (NP-01), is a programmed release formulation of low-dose prednisone that is marketed in Europe by the Company?s distribution partner, Mundipharma International Corporation Limited (Mundipharma). As of December 31, 2010, Horizon completed multiple Phase III clinical trials of LODOTRA. In addition to these product candidates, the Company has a pipeline of earlier-stage product candidates to treat pain-related diseases and chronic inflammation.

Stifel Nicolaus research focuses on all market caps, but is a leader in small- and mid-cap research. The department is staffed predominately with industry professionals from outside Wall Street. In fact, approximately 50% of its analysts have hands-on work experience in the industry that they research. Stifel Nicolaus believes industry experience, its opportunistic approach, and broad market cap coverage drive excess returns and its award-winning franchise.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/7/2011 8:25 AM Buy
8.35 12.00
as of 12/30/2011
1 Week down  -11.11 %
1 Month down  -23.22 %
3 Months down  -42.77 %
1 YTD down  -52.09 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy